Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Group Pharma | OTHER |
Not provided
Not provided
Not provided
Not provided
Aim of this study was to assess and compare the efficacy of a dentifrice containing 5% fluoro calcium phosphosilicate and dentifrice containing calcium sodium phosphosilicate on Dentinal Hypersensitivity (DH) compared to a placebo over a period of 6 weeks.
A total of 131 subjects were divided into 3 groups randomly. Group I was given the dentifrice containing 5% fluoro calcium phosphosilicate ,Group II was given the dentifrice containing calcium sodium phosphosilicate and group III was given placebo. Sensitivity scores (VAS score) were recorded at baseline, 2 weeks, 6 weeks.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group I | Active Comparator | dentifrice containing 5% fluorocalcium phospho silicate prescribed and VAS score assessed at Baseline, 2 weeks, 6 weeks. |
|
| Group II | Sham Comparator | dentifrice containing Calcium sodium phosphosilicate prescribed and VAS score assessed at Baseline, 2weeks, 6 weeks . |
|
| Group III | Placebo Comparator | dentifrice without the active ingredient prescribed and VAS score assessed at Baseline, 2weeks, 6 weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 5% fluorocalcium phosphosilicate dentifrice | Other | dentifrice containing 5% fluorocalcium phosphosilicate and VAS score assessed at Baseline, 2 weeks, 6 weeks. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Visual Analogue Scale score for Dentinal Hypersensitivity | Based on a 10-cm VAS score which was used to measure tooth sensitivity, a pain-free response was allotted a score of zero whereas a score of 10 was given to subjects with excruciating pain or discomfort. | Change in VAS score from Baseline to 6 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Avani R Pradeep, MDS | GDCRI, Bangalore, INDIA | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Periodontics, GDCRI Bangalore | Bangalore | Karnataka | 560002 | India |
Not provided
Not provided
Not provided
Not provided
Not provided
| Calcium sodium phosphosilicate | Other | Calcium sodium phosphosilicatand VAS score assessed at Baseline, 2weeks, 6 weeks. |
|
| Placebo dentrifice | Other | placebo dentifrice and VAS score assessed at Baseline, 2weeks, 6 weeks. |
|